Tuesday, August 02, 2016 4:37:25 PM
Unfortunately for NVIV shareholders, there are still only 8 evaluable patients now I believe (10 total minus 2 that died), at this rate it may take till end of 2017 to fully enroll, not end of 2016 like perrin says. I can see the pps here dropping to 2.50 / 3 area over the next few months if they don't start announcing bunches of enrollees soon. All IMHO, Do your own DD.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM